Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jul. 31, 2023	Jul. 31, 2022
Cash flow provided by (used in) operating activities:
Net income	$ 926,535	$ 645,964
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:
Depreciation and amortization	54,249	53,267
Stock-based compensation	21,290	19,258
Income (Loss) from unconsolidated entities	(20,813)	(27,954)
Distributions of earnings from unconsolidated entities	69,107	31,182
Deferred tax (benefit) provision	5,764	10,659
Impairment charges and write offs	40,137	17,473
Other	3,037	3,761
Changes in operating assets and liabilities
Inventory	(165,152)	(1,288,029)
Origination of mortgage loans	(1,137,893)	(1,390,630)
Sale of mortgage loans	1,248,621	1,513,603
Receivables, prepaid expenses and other assets	(34,667)	32,114
Current income taxes, net	(133,983)	(30,361)
Customer deposits, net	(26,384)	96,425
Accounts payable and accrued expenses	(174,815)	66,637
Net Cash Provided by (Used in) Operating Activities, Continuing Operations	675,033	(246,631)
Cash flow (used in) provided by investing activities:
Purchase of property, construction and office equipment - net	(54,100)	(56,485)
Investments in and advances to unconsolidated entities	(162,576)	(176,592)
Return of investments in unconsolidated entities	74,006	109,645
Proceeds from the sale of assets	9,041	28,309
Other	0	194
Net Cash (Used in) Provided By Investing Activities, Continuing Operations	(133,629)	(94,929)
Cash flow used in financing activities:
Proceeds from loans payable	2,413,016	2,950,869
Debt issuance costs	(5,324)	0
Principal payments of loans payable	(2,603,645)	(3,009,301)
Redemption of senior notes	(400,000)	(409,856)
(Payments) proceeds from stock-based benefit plans	47,091	(1,407)
Purchase of treasury stock	(239,320)	(383,886)
Dividends paid	(69,070)	(66,948)
Payments related to noncontrolling interests - net	0	(25,766)
Net Cash Used in Financing Activities, Continuing Operations	(857,252)	(946,295)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect	(315,848)	(1,287,855)
Cash, Cash Equivalents, and Restricted Cash , beginning of period	1,398,550	1,684,412
Cash, Cash Equivalents, and Restricted Cash, end of period	$ 1,082,702	$ 396,557